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Acute myocarditis (AM) diagnosis is a challenge based on the association of
clinical and para-clinical criteria. AM can favour the evolution towards dilated car-
diomyopathy. Three months after the acute episode, re-evaluation including car-
diac MRI attempts to identify patients at risk for unfavourable evolution. This use
of MRI has rarely been investigated in AM prognosis stratification.
Method and results: we report a prospective series of 27 consecutive
patients hospitalized for AM : 24 men, 3 women, 34 years old on average.
Physical examination found no sign of heart failure. All patients presented
with biological inflammatory syndrome and troponine I elevation. Echocardio-
graphy showed moderate global left ventricular dysfunction in 6 cases. There
were segmental wall motion abnormalities in 18 patients. Cardiac MRI per-
formed early after admission never showed myocardial first-pass perfusion
defect after gadolinium injection. There were subepicardial delayed-enhance-
ment (DE) areas in 25 cases. Holter monitoring did not show any rhythm
trouble. Angiography revealed normal coronary arteries.
Three months after all the patients were examined again. None were symp-
tomatic. Echocardiography and biological check-up were normal. Cardiac
MRI showed the persistence of DE in 14 patients without wall motion abnor-
mality in the affected segments. Holter monitoring remained normal.
Conclusions: at the time of admission, the absence of early perfusion
defect after gadolinium injection and the subepicardial localization of the DE
constitute reliable criteria in favour of AM diagnosis, allowing to rule out an
acute coronary syndrome. Furthermore the existence of a DE allows to assess
the localization and the extension of the inflammation in a non-invasive way.
During the follow-up the persistence of a DE does not allow any prognosis
stratification and is not associated with any clinical and para-clinical disorders.
However the persistence of a DE encourages a more rigorous follow-up.
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Background: Cardiogenic unilateral pulmonary oedema (UPE) is rare and
often misdiagnosed. The aim of our study was to determine the prevalence
of UPE; the clinical characteristics and the outcomes of this particular form of
cardiogenic pulmonary oedema.
Methods: A retrospective study that enrolled all consecutive patients
admitted in the two intensive care units of a French University Hospital for
cardiogenic pulmonary oedema from January 2000 to may 2008.
Results: 869 consecutive patients (475 men, 394 women; mean age 75.4 +/
- 13.0 were hospitalized during this period. Among this population, 18 patients
(10 men, 8 women; mean age 76.4 +/- 12.9, range 46 to 94 years) presented
with radiological features of unilateral pulmonary edema resulting in a preva-
lence of 2%. UPE was right-sided in 16 cases and left-sided in 2. UPE was
associated in all cases with a severe mitral regurgitation (MR). 53 additional
patients presented a bilateral pulmonary edema (BPE) associated with severe
MR. Clinical and echocardiographic features were similar between patients
with UPE or BPE due to severe MR. However, patients with UPE required
significantly more use of non-invasive or invasive ventilation (p= 0.008) and
catecholamines (p = 0.01) than patients with classical BPE due to severe MR.
Use of antibiotherapy was significantly higher in patients with UPE than in
patients with BPE associated with severe MR (11/18 Vs 3/53, p < 0.0001).
Mortality was significantly higher in patients with UPE (39%) than in patients
with BPE (6%) due to severe MR in univariate analysis [OR=10.6, (95% CI :
2.4 – 47), p=0.0021] and in multivariate analysis [OR=8.4, (95% CI : 1.5 –
47), p=0.015].
Conclusion: In our study, unilateral pulmonary oedema represents 2% of
all cardiogenic pulmonary edema and usually appears as an opacity involving
the right upper lobe. Because of the risk of misdiagnosis (pneumonia, neo-
plasm), UPE has to be known to avoid delays in treatment that may affect
prognosis.
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Echocardiographic evaluation of left and right ventricular functions
in familial amyloidosis polyneuropathy: preserved or not?
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Familial amyloidosis polyneuropathy (FAP) is an inherited disease caused
by mutated transthyretin, with neuropathy, conduction disorders, and cardiac
denervation. Orthotopic liver transplantation is the only treatment improving
prognosis. Pre operative cardiac evaluation is important.
The aim of the study is to assess LV and RV systolic functions in 32 con-
secutive patients prospectively included between January 2007 and August
2008, compared to 36 healthy controls.
LV global systolic function (ejection fraction, tei index, MAPSE) was
normal in all subjects but significantly lower in patients. Cardiac index was
higher in controls (p = 0,02). LV regional systolic function analysed by peak
systolic velocity at TDI at the 4 walls, showed an impairement in FAP patients
(p<0,0001). Elevated LV living pressure defined as E/Em>10, was more fre-
quent in FAP (p<0,0001).
FAP patients presented with significantly lower RV systolic function
(TAPSE, systolic peak at tricuspid annulus). Elevated RV filling pressure
defined as E/Et>6 was more frequent in patients (p=0,001).
Although the LV and RV systolic function is classically preserved at FAP,
this study shows that it is significantly decreased compared to controls, with
an early regional systolic dysfunction. Echocardiographic evaluation allows
early detection of restrictive cardiopathy.
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Latent obstruction elicits a rapid proteolysis of von Willebrand factor
in patients with hypertrophic cardiomyopathy. A rest and exercise
echocardiographic study
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Background: Latent obstruction in hypertrophic cardiomyopathy (HCM)
have clinical and prognostic consequences. Baseline obstruction impairs hemo-
static properties of von Willebrand factor (VWF) in HCM.
Objectives: We sought to assess the acute effect of exercise-induced
obstruction on VWF in patients with latent obstruction, and the determinants
of obstruction and VWF impairment.
Methods: A comprehensive echocardiography was performed at rest and
during exercise in 32 patients with HCM. Sixteen patients (44±16 years) with
latent obstruction (baseline peak gradient < 30 mmHg and exercise peak gra-
dient≥30 mmHg) were matched with 16 patients without obstruction. Maximal
peak gradient was recorded; the type and duration of obstruction during exer-
cise were characterized by an obstruction score. Blood was sampled before
and after exercise.
Results: Baseline median [25-75th percentiles] peak gradient was 8[6-11]
mmHg, and rose up to 32[17-104] mmHg with exercise. Baseline predictors of
exercise-induced obstruction (R_ of the model 0.66) were incomplete SAM
(r=0.76, p<0.0001) and mitral S velocity (r=0.34, p=0.004). At rest, VWF
function was modestly impaired in patients with latent obstruction. VWF-col-
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lagen binding activity to antigen ratio (VWF:CB/Ag) and the percentage of
high molecular weight multimers of VWF (%HMWM) did not change after
exercise in the non obstructive group but were lowered in patients with latent
obstruction (both p=0.003). Incomplete SAM at rest was the strongest inde-
pendent predictor of%HMWM drop (r=-0.70, p<0.0001). %HMWM after
exercise tightly correlated with exercise peak gradient (r=-0.78, p<0.0001) and
the persistence of obstruction during recovery (r=-0.67, p=0.005).
Conclusion: Incomplete SAM and mitral S velocity at rest are the main
predictors of latent obstruction in HCM. Latent obstruction elicits a rapid
cleavage of the largest multimers of VWF which is related to the peak gra-
dient but also to the persistence of obstruction during recovery.
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Implementation of patients reaction is better than implementation of
knowledge in Heart failure patients
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ret, Michel Desnos
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Heart failure remains a disease with poor prognosis despite the therapeutic
advances of recent decades. Nearly a third of hospital admissions are due to
errors in dietetics follow up or therapeutic monitoring. Therapeutic education
of patients with heart failure is growing fast in France. For the "Haute autorité
de santé" (HAS), evaluation of education programs is an essential element in
the same way that the educational diagnosis and interactivity. We wanted to
determine what the assessment could predict the onset of the test combined
death and hospitalization for heart failure.
We included 398 patients with systolic heart failure who received a thera-
peutic education between 2003 and 2008. The program involved an educa-
tional diagnosis individual training sessions with the disease, sessions
Implementation situation, self-physical and dietary. During this educational
process, patients filled a questionnaire initial knowledge (Q1) and a question-
naire at the end of training (Q2) and one year of it (Q3). They also fulfilled a
clinical case assessment and post training within one year.
The average age of patients was 65 (± 4), LVEF of 34 (± 4), the average
BNP of 235 (± 346). There is no correlation between the scores of knowledge
questionnaires and questionnaires of clinical cases. In ROC curve there is no
cut off for predicting the occurrence of a major event. In survival curve there
is no difference between patients having a response greater than the median at
questionnaire1, 2 or 3. however patients with a clinical performance at post
training clinical cases above the median had an event-free survival signifi-
cantly better than those with a response below the median (p <0001).
Conclusion: The evaluation of the reactions of patients with clinical cases
is greater than the simple evaluation of the knowledge of patients in terms of
predicting survival without hospitalization for heart failure.
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Background: B-type natriuretic peptide (BNP) (Advia Centaur System) and
left atrial volume index (LAVi) are regarded as powerful markers of global myo-
cardial function. Several confounding factors are known to potentially influence
this relation. The aim of the present study was to evaluate the determinants of BNP
and LAVi in the same population of stable patients referred for catheterism.
Methods: 74 consecutive patients were included. Exclusion criteria were
arrhythmias, acute coronary syndrome, exacerbation of heart failure and severe
left-sided valve disease. All the data were obtained within the same morning for
each patient. All following variables were tested: age, gender, body mass index,
systolic arterial pressure, heart rate, LV ejection fraction (LVEF), LV mass index
(LVM), significant mitral regurgitation (MR), serum hemoglobin (Hb), creatinine
clearance (CC), LV end-diastolic pressure (LVEDP), extent of coronary disease.
Results: Univariate determinants of BNP were age, LVEF, LVM, MR,
LVEDP, extent of coronary disease, Hb and CC. By multiple regression anal-
ysis, the independant determinants of BNP were age, LVEDP and LVEF
(p<0,005 for all). Univariate determinants of LAVI were age, significant MR,
LVM, LVEF and LVEDP. By multiple regression analysis, the independent
predictors were LVM and LVEDP (p=0,001 for all). BNP was not predicted
by LAVi in the multivariate model.
Conclusion: Our study confirms that both BNP and LAVi can be used as
markers of global myocardial dysfunction in stable patients in sinus rhythm. How-
ever, age must be taken into consideration before interpreting BNP results.
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Rationale: The part of elderly patients (pts) in heart failure (HF) popula-
tion is growing. They might pose specific problems due to the greater propor-
tion of HF with preserved LVEF, more frequent comorbidities or contra-
indications to recommended HF treatment.
Objectives: to describe the care management of pts > 80-year treated for
HF in France.
Methods: Cross sectional observational survey with retrospective collec-
tion of data at hospital discharge. Pts must have been diagnosed with CHF and
have been hospitalised for CHF within the previous 18 months. Pts are classi-
fied according to the LVEF at hospital discharge.
Results: 412 French outhospital cardiologists entered 1 452 pts meeting the
inclusion criteria. FEVG at hospital discharge was known for 1408 pts. 355
(25%) were more than 80-year-old. Management care at hospital discharge
according to age and LVEF is detailed below.
 
 
LVEF 
< 40%
LVEF 
40-50%
LVEF 
> 50% Total
Age>80
 
 
 
 
 
 
ACEI/ARB 84% 81% 80% 82%*
BB 71% 67% 40%†‡ 62%*
Loop diuretics 92% 85% 85% 88%
Spironolactone/eplerenone 26% 20% 18% 22%*
Digoxin 20% 15% 29% 21%*
Calcium antagonists 10% 14% 37%†‡ 18%
Anticoagulants 49% 45% 51% 49%*
Age≤80
 
 
 
 
 
 
ACEI/ARB 93% 93% 85%†‡ 92%
BB 79% 78% 76% 79%
Loop diuretics 90% 82% 79%†§ 86%
Spironolactone/eplerenone 35% 21% 25%†§ 30%
Digoxin 16% 15% 16% 15%
Calcium antagonists 9% 19% 21%†§ 13%
Anticoagulants 42% 39% 39% 41%
†p<0.05 for comparisons between LVEF > 50% and LVEF<40%; 
‡ p<0.05 for comparisons between LVEF>50% and LVEF between 40% 
and 50%; 
§: p<0.05 for comparisons between LVEF<40% and LVEF between 40% 
and 50%; 
* p<0.05 for comparisons between > 80 and ≤ 80 years old adjusted for 
LVEF.
